Pharmaceutical market

The pharmaceutical market encompasses the development, production and sale of medicines needed to improve health and treat disease. Our site offers articles that explore current industry trends, including innovations in drug therapies, and analyze the impact of global regulatory changes on access to medicines.

Learn about key challenges and opportunities in the market, including patent wars, pricing, and clinical trial milestones. Gain insights on strategies for navigating the complex regulatory environment and optimizing processes to accelerate innovation and ensure patient safety.

uzbek dialysis patient plasma medicine

Uzbekistan Plans for Locally Produced Blood Plasma-Derived Medicines

Uzbekistan is strengthening its pharmaceutical industry by focusing on the development of locally produced blood plasma-derived medicines.  The government has implemented legislative changes and investment plans to modernize the country’s blood collection, processing, and plasma-derived medicine production capabilities. Investment Plans for Blood Collection, Processing, and Plasma-Derived Medicine Production The government has recently implemented legislative amendments […]

Uzbekistan Plans for Locally Produced Blood Plasma-Derived Medicines Read More »

eaeu unified pvg inspection rules delta medical

EEC Council Adopts Uniform Rules for Pharmacovigilance Inspections in EAEU

The Council of the Eurasian Economic Commission (EEC) has taken a significant step towards harmonizing the pharmaceutical regulatory landscape across the Eurasian Economic Union (EAEU) member states.  In a recent decision taken on 12 April 2024, the EEC Council supplemented Decision No. 83 dated 03.11.2016 with the Rules for conducting pharmaceutical inspections to ensure compliance

EEC Council Adopts Uniform Rules for Pharmacovigilance Inspections in EAEU Read More »

babushka russian pharmacy medicine

India Overtakes Germany as Largest Supplier of Medicines to Russian Market

In 2023, India surpassed Germany to become the largest foreign supplier of medicines to the Russian market. This shift comes amidst European countries reducing sales of original drugs due to the emergence of analogues and market restrictions. The following analysis provides insights into the changing dynamics of the Russian pharmaceutical import market. Key Findings In

India Overtakes Germany as Largest Supplier of Medicines to Russian Market Read More »

Kazakh youtuber sitting desk

New Influencer Marketing Rules in Kazakhstan

The government of Kazakhstan has introduced new regulations requiring bloggers and influencers to clearly label sponsored content on social platforms. These rules, which take effect 2 March 2024, aim to bring more transparency to the country’s online advertising industry. For pharmaceutical companies marketing medicines in Kazakhstan, understanding the key aspects of these blogger guidelines will

New Influencer Marketing Rules in Kazakhstan Read More »

Pharmacy Russia modern

Expanding Pharmacy Chains Consolidate Russian Market

Over the past few years, Russia has seen immense growth in its pharmacy industry led by the expansion of large pharmacy chains. As of 2023, there are over 77,000 pharmacies across Russia, up 4.6% from 2022. Pharmacy chains now account for 91.7% of total pharmacy revenue in the country. Russian Pharmacy Chains Consolidating Market Through

Expanding Pharmacy Chains Consolidate Russian Market Read More »

Kazakh customs broker

Expanded Customs Declaration Data Proposed for Pharmaceutical Imports into the EAEU

The Eurasian Economic Commission has proposed changes to customs declarations that would impact pharmaceutical companies shipping products into the EAEU market.

Expanded Customs Declaration Data Proposed for Pharmaceutical Imports into the EAEU Read More »

Digitalizing Europe: access to health data without borders

Health information will be available to European Union citizens digitally, free of charge and in all EU countries. The European Parliament supported the European Commission’s proposal to create a pan-European health data space for patients, healthcare providers and researchers.

Digitalizing Europe: access to health data without borders Read More »

Acino Spins Off Embattled Russian Division into New Company Alcea

As war rages in Ukraine and tensions between Russia and the West escalate, Swiss pharmaceutical giant Acino International has made the strategic decision to spin-off its Russian division Acino Rus into a separate independent entity called Alcea. Acino had expanded in Russia since 2015, achieving double-digit growth in recent years largely driven by sales of

Acino Spins Off Embattled Russian Division into New Company Alcea Read More »

Scroll to Top